Michigan Patent of the Month – January 2025
Spectrum Health has developed an innovative method for treating pediatric developmental disorders linked to a mutation in the ODC1 gene. This discovery focuses on disorders that cause symptoms like macrosomia, macrocephaly, developmental delay, spasticity, hypotonia, and delayed visual maturation. These conditions result from a gain-of-function mutation in the ODC1 gene, which leads to an increase in polyamine levels, particularly putrescine.
The treatment involves administering eflornithine (DFMO), a well-known polyamine synthesis inhibitor, which has shown promise in addressing the elevated polyamine levels associated with these mutations. Spectrum Health’s approach may significantly alter the way these disorders, such as Bachmann-Bupp Syndrome (BABS) and Snyder-Robinson syndrome, are treated. By targeting the ODC enzyme, which plays a pivotal role in polyamine metabolism, the therapy could alleviate developmental delays and associated physical disabilities.
What sets this invention apart is its precision. It identifies specific genetic mutations, such as the c.1342 A>T nonsense mutation, and tailors treatment to the unique genetic profiles of affected individuals. The method may be even more effective if eflornithine is administered before the age of five, allowing for early intervention in developmental processes. Additionally, combining eflornithine with other agents, such as GC7 inhibitors or polyamine uptake inhibitors, could further enhance treatment outcomes.
This breakthrough represents not only a step forward in understanding the underlying causes of certain developmental disorders but also a potential game-changer in how these conditions are treated. The use of targeted genetic therapies could pave the way for more personalized and effective treatments in the future, offering hope for children affected by these complex conditions.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
